TGFB1 and neoplasm: Interestingly, various components of TGF-β signaling pathways are known to be primarily mutated in distinct tumor types such as colon, ovarian, and uterian carcinomas, but strongly amplified in breast, lung, pancreas, esophagus, and stomach carcinomas61.